HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaki Hayakawa Selected Research

Hyperglycemia

1/2018GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaki Hayakawa Research Topics

Disease

7Thrombotic Thrombocytopenic Purpura
01/2022 - 01/2012
6Thrombosis (Thrombus)
04/2021 - 09/2012
5Hemorrhage
11/2021 - 10/2016
4acquired Thrombotic thrombocytopenic purpura
04/2021 - 03/2016
2COVID-19
01/2022 - 04/2021
2Macular Degeneration (Age-Related Maculopathy)
10/2021 - 01/2018
2Thrombocytopenia (Thrombopenia)
04/2021 - 03/2016
2Disseminated Intravascular Coagulation
04/2021 - 04/2021
2Aortic Valve Stenosis (Aortic Stenosis)
01/2020 - 10/2016
2Glucose Intolerance
02/2018 - 01/2018
2Thrombotic Microangiopathies
09/2016 - 01/2012
1Evans Syndrome
01/2022
1Broca Aphasia (Expressive Aphasia)
01/2022
1Essential Thrombocythemia
01/2022
1Bradycardia
10/2021
1Sudden Death
10/2021
1Hypotension (Low Blood Pressure)
10/2021
1Wounds and Injuries (Trauma)
06/2021
1Hemolysis
06/2021
1Thromboembolism
04/2021
1Pneumonia (Pneumonitis)
04/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Factor V Deficiency
01/2020
1Femoral Fractures (Femoral Fracture)
01/2020
1Infections
01/2020
1Chronic Kidney Failure (Chronic Renal Failure)
01/2020
1Multiple Myeloma
01/2020
1Neoplasms (Cancer)
01/2020
1Paraproteinemias (Monoclonal Gammopathy)
01/2020
1Wound Infection (Wound Infections)
01/2020
1Reperfusion Injury
11/2019
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
07/2019
1Inflammation (Inflammations)
07/2019
1Body Weight (Weight, Body)
02/2018
1Hyperphagia (Overeating)
01/2018
1Hyperglycemia
01/2018
1Abdominal Obesity
01/2018
1Obesity
01/2018
1Angiodysplasia
09/2017
1HELLP Syndrome
09/2017
1Disease Progression
01/2017
1Liver Diseases (Liver Disease)
01/2017
1Protein S Deficiency (Deficiency, Protein S)
09/2016
1Pulmonary Embolism
09/2016
1Human Influenza (Influenza)
09/2016
1Rupture
03/2016
1Abdominal Aortic Aneurysm
03/2016
1Aneurysm (Aneurysms)
03/2016
1Brain Diseases (Brain Disorder)
04/2015

Drug/Important Bio-Agent (IBA)

11von Willebrand FactorIBA
01/2022 - 12/2013
8thiamine triphosphorate (TTP)IBA
10/2021 - 01/2012
5AutoantibodiesIBA
12/2020 - 03/2016
4SteroidsIBA
01/2022 - 04/2015
3AntigensIBA
04/2021 - 10/2016
2AntibodiesIBA
11/2021 - 10/2003
2Metalloproteases (Metalloproteinases)IBA
11/2021 - 09/2016
2ThrombospondinsIBA
11/2021 - 09/2016
2DisintegrinsIBA
11/2021 - 09/2016
2AnticoagulantsIBA
04/2021 - 01/2020
2Dacarbazine (DIC)FDA LinkGeneric
04/2021 - 04/2021
2Rituximab (Mabthera)FDA Link
12/2020 - 01/2017
2Intravenous Immunoglobulins (IVIG)FDA Link
07/2019 - 04/2017
2Glucagon-Like Peptide 1 (GLP 1)IBA
02/2018 - 01/2018
2psicose (D-psicose)IBA
02/2018 - 01/2018
1VaccinesIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1antineoplaston A10 (A 10)IBA
11/2021
1formycin diphosphate (FDP)IBA
04/2021
1Heparin (Liquaemin)FDA LinkGeneric
04/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1Factor V (Coagulation Factor V)IBA
01/2020
1ParaproteinsIBA
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1afliberceptIBA
01/2018
1Capsules (Microcapsules)IBA
09/2017
1GlucocorticoidsIBA
04/2017
1Biological ProductsIBA
04/2017
1Immunoglobulins (Immunoglobulin)IBA
04/2017
1Protein SIBA
09/2016
1CytokinesIBA
09/2016
1Blood Substitutes (Artificial Blood)IBA
03/2016
1Shiga Toxin (Shigella Toxin)IBA
04/2015
1ThrombomodulinIBA
04/2015

Therapy/Procedure

5Plasma Exchange
10/2021 - 04/2015
2Platelet Transfusion (Blood Platelet Transfusions)
01/2022 - 03/2016
2Heart-Assist Devices
06/2021 - 01/2020
2Therapeutics
04/2021 - 01/2017
1Plasmapheresis
01/2022
1Extracorporeal Membrane Oxygenation
04/2021
1Off-Label Use
12/2020
1Debridement
01/2020
1Renal Dialysis (Hemodialysis)
01/2020
1Replacement Arthroplasty
01/2020
1Hepatectomy
11/2019
1Intravitreal Injections
01/2018
1Central Venous Catheters
09/2016
1Perioperative Period
03/2016
1Blood Vessel Prosthesis Implantation
03/2016
1Hemodiafiltration
04/2015